Occult recurrent breast cancer masquerading as thrombotic thrombocytopenic purpura

Affiliations

¹ Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
² Departments of Epidemiology & Biostatistics, Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
⁴ Division of Hematology, Department of Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida, USA.

Free article

Case Reports

Beatriz Wills-Sanin et al. Am J Hematol. 2023 May.

Free article

. 2023 May;98(5):830-832.

doi: 10.1002/ajh.26761. Epub 2022 Oct 28.

¹ Division of Hematology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
² Departments of Epidemiology & Biostatistics, Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
³ Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
⁴ Division of Hematology, Department of Medicine, University of Miami/Sylvester Comprehensive Cancer Center, Miami, Florida, USA.

Abstract

GATA3 immunohistochemistry stain of the bone marrow biopsy required to diagnose recurrent metastatic breast cancer.